Delmonico Lucas, Bravo Maryah, Silvestre Rafaele Tavares, Ornellas Maria Helena Faria, De Azevedo Carolina Maria, Alves Gilda
Research Coordination, National Cancer Institute, Rio de Janeiro 20230-130, Brazil; Graduate Program of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro 20550-170, Brazil; Circulating Markers Laboratory, Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro 20550-170, Brazil.
Research Coordination, National Cancer Institute, Rio de Janeiro 20230-130, Brazil; Circulating Markers Laboratory, Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro 20550-170, Brazil.
Oncol Lett. 2016 Sep;12(3):2145-2152. doi: 10.3892/ol.2016.4828. Epub 2016 Jul 8.
The present study evaluated the proteomic profile of saliva and plasma from women with impalpable breast lesions using nano-liquid chromatography-quadrupole-time-of-flight (nLC-Q-TOF) technology. Plasma and saliva from patients with fibroadenoma (n=10), infiltrating ductal carcinoma (n=10) and healthy control groups (n=8) were assessed by combinations of inter/intra-group analyses, revealing significant quantitative and qualitative differences. The major differentially-expressed proteins in the saliva of patients compared with the controls were α2-macroglobulin and ceruloplasmin, but the proteins that met the minimum fold-change and P-value cut-offs were leukocyte elastase inhibitor and α-enolase, and deleted in malignant brain tumors 1. Concerning plasma, α-2-macroglobulin and ceruplasmin were upregulated, while other proteins such as haptoglobin, hemopexin and vitamin D-binding protein were downregulated compared with the control. The changes in immune, molecular transport and signaling pathways were the most representative in the proteomic profile of the saliva and plasma. This is the first study to describe the proteome of saliva and plasma from the same women with impalpable breast lesions.
本研究采用纳升液相色谱-四极杆-飞行时间质谱(nLC-Q-TOF)技术,评估了患有不可触及乳腺病变的女性唾液和血浆的蛋白质组学特征。通过组间/组内分析组合,对纤维腺瘤患者(n = 10)、浸润性导管癌患者(n = 10)和健康对照组(n = 8)的血浆和唾液进行了评估,发现存在显著的定量和定性差异。与对照组相比,患者唾液中主要的差异表达蛋白是α2-巨球蛋白和铜蓝蛋白,但满足最小倍数变化和P值临界值的蛋白是白细胞弹性蛋白酶抑制剂和α-烯醇化酶,以及恶性脑肿瘤缺失蛋白1。在血浆方面,与对照组相比,α-2-巨球蛋白和铜蓝蛋白上调,而其他蛋白如触珠蛋白、血红素结合蛋白和维生素D结合蛋白下调。免疫、分子转运和信号通路的变化在唾液和血浆的蛋白质组学特征中最具代表性。这是第一项描述患有不可触及乳腺病变的同一女性唾液和血浆蛋白质组的研究。